Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials
Helios Dr. Horst Schmidt Kliniken Wiesbaden · Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe · +4 more institutions
Abstract
Primary surgery followed by platinum-taxane based chemotherapy has been the standard therapy in advanced ovarian cancer. However, the prognostic role of complete and so-called optimal and suboptimal debulking and its interaction with biological factors has not been not fully defined.
Exploratory analysis was conducted of 3 prospective randomized trials (AGO-OVAR 3, 5, and 7) investigating platinum-taxane based chemotherapy regimens in advanced ovarian cancer conducted between 1995 and 2002.
Citation impact
- FWCI
- 50.18
- Percentile
- 100%
- References
- 37
Authors
6- ADAndreas du BoisCorresponding
Helios Dr. Horst Schmidt Kliniken Wiesbaden, Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe
- ARAlexander Reuß
Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe
- EPEric Pujade‐Lauraine
Hôtel-Dieu de Paris
- PHPhilipp Harter
Helios Dr. Horst Schmidt Kliniken Wiesbaden, Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe
- IRIsabelle Ray‐Coquard
Centre Léon Bérard
Topics & keywords
- Medicine
- Taxane
- Debulking
- Oncology
- Ovarian cancer
- Internal medicine
- Stage (stratigraphy)
- Chemotherapy
- Good health and well-being